Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isolation and characterization of process-related impurities in linezolid.
Krishna Reddy KV, Mahender Rao S, Om Reddy G, Suresh T, Moses Babu J, Dubey PK, Vyas K. Krishna Reddy KV, et al. Among authors: om reddy g. J Pharm Biomed Anal. 2002 Oct 15;30(3):635-42. doi: 10.1016/s0731-7085(02)00353-9. J Pharm Biomed Anal. 2002. PMID: 12367688
Structural studies on the impurities of troglitazone.
Moses Babu J, Nageshwar D, Ravindra Kumar Y, Prabhakar C, Sarma MR, Om Reddy G, Vyas K. Moses Babu J, et al. Among authors: om reddy g. J Pharm Biomed Anal. 2003 Feb 26;31(2):271-81. doi: 10.1016/s0731-7085(02)00665-9. J Pharm Biomed Anal. 2003. PMID: 12609666
Sparfloxacin, an antibacterial drug.
Sivalakshmidevi A, Vyas K, Om Reddy G. Sivalakshmidevi A, et al. Among authors: om reddy g. Acta Crystallogr C. 2000 Mar 15;56(Pt 3):E115-6. doi: 10.1107/S0108270100002523. Epub 2000 Mar 15. Acta Crystallogr C. 2000. PMID: 15263223
A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phase.
Rao BM, Ravi R, Shyam Sundar Reddy B, Sivakumar S, Gopi Chand I, Praveen Kumar K, Acharyulu PV, Om Reddy G, Srinivasu MK. Rao BM, et al. Among authors: om reddy g. J Pharm Biomed Anal. 2004 Sep 3;35(5):1017-26. doi: 10.1016/j.jpba.2004.03.015. J Pharm Biomed Anal. 2004. PMID: 15336349